The utility of cfDNA as a diagnostic tool in the management of EGFR-mutated non-small cell lung cancer (NSCLC): our regional off-study experience

Autor: Nageshwaran, S., Ping, B., Mehta, A., Ezhil, V., Feng, G., Hall, J., Shaheed, M., Amin, N., Faulkes, C., Collins, N., Illsley, M., Matthew, H., Bagwan, I., Lee, K., Hewish, M.
Zdroj: In Lung Cancer January 2019 127 Supplement 1:S15-S15
Databáze: ScienceDirect